首页> 外文期刊>Stem Cell >Comparative Study between Low Molecular Weight Heparin and Unfractionated Heparin on Lipids in Hemodialysis Patients
【24h】

Comparative Study between Low Molecular Weight Heparin and Unfractionated Heparin on Lipids in Hemodialysis Patients

机译:低分子肝素和普通肝素对血液透析患者血脂的比较研究

获取原文
       

摘要

Objective: To evaluate effects of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) on the level of triglycerides, cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) on hemodialysis patients. Background: End stage renal disease (ESRD) patients have a high risk of mortality, with cardiovascular diseases (CVD) being the commonest cause of death. Dyslipidemia is a major cause of CVD. A number of studies had evaluated the effect of both UFH and LMWH on lipid metabolism in ESRD patients. Methods: This study subjecting fifty patients with ESRD onmaintenance hemodialysis (HD) and last for six months. Twenty five patients using LMWH (enoxaparin) (9male and 16female) with mean age of 54.280 ± 6.668years and twenty five patients using UFH (13 male and 12 female) with mean age 56.920 ± 9.050 years. Serum cholesterol, triglycerides, HDL and LDL were determined. Demographic data and laboratory values were evaluated. Results: Our results show no significant difference between both groups regarding triglycerides level after the study (P=0.741) with more numerical decrease in triglycerides level in LMWH group (P=0.244). A significant increase in cholesterol level were found in UFH group after the study (P=0.009). Also the results show a significant increase in bleeding events in UFH group (P=0.020) and significant increase in coagulation problems in LMWH group (P=0.024). Conclusions: The results of this study indicate a more decrease in triglycerides level in patients using LMWH than UFH with significant increase in cholesterol level in UFH group. There were a significant increase in bleeding events in UFH patients and an increase in coagulation events in patients using LMWH. So we suggest using LMWH in patients with high serum cholesterol, triglyceridesand history of bleeding disorders and using UFH in patients with coagulation disorders.
机译:目的:评价普通肝素(UFH)和低分子量肝素(LMWH)对血液透析患者甘油三酯,胆固醇,高密度脂蛋白(HDL)和低密度脂蛋白(LDL)水平的影响。背景:终末期肾病(ESRD)患者具有很高的死亡风险,其中心血管疾病(CVD)是最常见的死亡原因。血脂异常是CVD的主要原因。大量研究评估了UFH和LMWH对ESRD患者脂质代谢的影响。方法:本研究对50例ESRD患者进行了维持性血液透析(HD),持续了六个月。 25名使用LMWH(依诺肝素)的患者(9名男性和16名女性)平均年龄为54.280±6.668岁,25名使用UFH的患者(13名男性和12名女性)平均年龄为56.920±9.050岁。测定血清胆固醇,甘油三酸酯,HDL和LDL。人口统计学数据和实验室值进行了评估。结果:我们的结果显示,研究后两组之间的甘油三酸酯水平无显着差异(P = 0.741),而LMWH组中甘油三酸酯水平的数值下降更多(P = 0.244)。研究后,UFH组的胆固醇水平显着增加(P = 0.009)。结果还显示,UFH组的出血事件显着增加(P = 0.020),而LMWH组的凝血问题显着增加(P = 0.024)。结论:这项研究的结果表明,使用LMWH的患者的甘油三酸酯水平下降比UFH更大,而UFH组的胆固醇水平明显升高。 UFH患者的出血事件显着增加,而LMWH患者的凝血事件则增加。因此,我们建议在血清胆固醇高,甘油三酸酯高和有出血性疾病史的患者中使用LMWH,而在凝血性疾病的患者中使用UFH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号